Literature DB >> 16078111

Magnetic resonance imaging and biological markers in pituitary adenomas with invasion of the cavernous sinus space.

Li-Xiong Pan1, Zhong-Ping Chen, Yun-Sheng Liu, Ji-Hong Zhao.   

Abstract

The preoperative diagnosis of cavernous sinus invasion remains difficult and controversial, and there are currently no reliable histological or molecular markers that predict pituitary tumour behaviour and response to treatment. We evaluated 45 patients with pituitary adenoma. The results have shown that the sensitivity of MRI for indicating cavernous sinus invasion in this prospective study was 60%, specificity 85%, positive predictive value 83.33%, negative predictive value 62.96%. Forty-five specimens of pituitary adenomas were analyzed for expression of F8, VEGF, Ki-67, c-myc, bcl-2, nm23 and MMP-9 immunoreactivity using immunoperoxidase staining. MVD was assessed using F8-related antigen. The results have shown that MVD of invasive pituitary adenomas was significantly higher than that of noninvasive (P < 0.001). There was an association between the invasion of pituitary adenomas and Ki-67 LI (P = 0.039) or the expression of VEGF (P < 0.001) and MMP-9 (P < 0.001). But c-myc LI and bcl-2 expression have no association with invasiveness of pituitary adenomas (P = 0.061 vs. P = 0.201). On the other hand, there is an inverse relationship between nm23 expression and tumor invasion (P < 0.001). In conclusion, parasellar extension of pituitary adenomas through the medial wall of the cavernous sinus diagnosed at surgery, can be determined by radiology with sensitive gadolinium-enhanced MRI. Although our study has shown that MVD and the expression of VEGF, Ki-67, nm23 and MMP-9 have associations with invasiveness of pituitary adenomas, they are lack of specificity. These markers can only provide some useful informations on the therapeutic strategy of pituitary adenomas.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16078111     DOI: 10.1007/s11060-004-6150-9

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  35 in total

Review 1.  Metastasis suppressor genes: basic biology and potential clinical use.

Authors:  Patricia S Steeg; Taoufik Ouatas; Douglas Halverson; Diane Palmieri; Massimiliano Salerno
Journal:  Clin Breast Cancer       Date:  2003-04       Impact factor: 3.225

Review 2.  Monoclonal antibody Ki-67: its use in histopathology.

Authors:  D C Brown; K C Gatter
Journal:  Histopathology       Date:  1990-12       Impact factor: 5.087

3.  Differential expression of p16/p21/p27 and cyclin D1/D3, and their relationships to cell proliferation, apoptosis, and tumour progression in invasive ductal carcinoma of the breast.

Authors:  S C Wong; J K Chan; K C Lee; W L Hsiao
Journal:  J Pathol       Date:  2001-05       Impact factor: 7.996

Review 4.  Intratumoral vascularity as a prognostic factor in cancers of the urogenital tract.

Authors:  N Weidner
Journal:  Eur J Cancer       Date:  1996-12       Impact factor: 9.162

5.  Vascular endothelial growth factor expression in preoperative biopsy specimens correlates with disease recurrence in patients with early gastric carcinoma.

Authors:  K Maeda; S M Kang; N Onoda; M Ogawa; Y Kato; T Sawada; K H Chung
Journal:  Cancer       Date:  1999-08-15       Impact factor: 6.860

6.  Expression of bcl-2 oncoprotein in pituitary tumours: comparison with c-myc.

Authors:  D G Wang; C F Johnston; A B Atkinson; A P Heaney; M Mirakhur; K D Buchanan
Journal:  J Clin Pathol       Date:  1996-10       Impact factor: 3.411

7.  bcl-2 and apoptosis in lymph node positive breast carcinoma.

Authors:  M D Berardo; R M Elledge; C de Moor; G M Clark; C K Osborne; D C Allred
Journal:  Cancer       Date:  1998-04-01       Impact factor: 6.860

8.  Reduced expression of nm23-H1, but not of nm23-H2, is concordant with the frequency of lymph-node metastasis of human breast cancer.

Authors:  Y Tokunaga; T Urano; K Furukawa; H Kondo; T Kanematsu; H Shiku
Journal:  Int J Cancer       Date:  1993-08-19       Impact factor: 7.396

9.  Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis.

Authors:  B H Bochner; R J Cote; N Weidner; S Groshen; S C Chen; D G Skinner; P W Nichols
Journal:  J Natl Cancer Inst       Date:  1995-11-01       Impact factor: 13.506

10.  Inverse association of nm23-H1 expression by colorectal cancer with liver metastasis.

Authors:  A Yamaguchi; T Urano; S Fushida; K Furukawa; G Nishimura; Y Yonemura; I Miyazaki; G Nakagawara; H Shiku
Journal:  Br J Cancer       Date:  1993-11       Impact factor: 7.640

View more
  15 in total

Review 1.  Euclidean and fractal geometry of microvascular networks in normal and neoplastic pituitary tissue.

Authors:  Antonio Di Ieva; Fabio Grizzi; Paolo Gaetani; Umberto Goglia; Manfred Tschabitscher; Pietro Mortini; Riccardo Rodriguez y Baena
Journal:  Neurosurg Rev       Date:  2008-03-08       Impact factor: 3.042

2.  Over-expression of vascular endothelial growth factor in pituitary adenomas is associated with extrasellar growth and recurrence.

Authors:  Ruth Sánchez-Ortiga; Laura Sánchez-Tejada; Oscar Moreno-Perez; Pedro Riesgo; Maria Niveiro; Antonio M Picó Alfonso
Journal:  Pituitary       Date:  2013-09       Impact factor: 4.107

3.  Phosphorylation of cAMP response element binding protein (CREB) as a marker of hypoxia in pituitary adenoma.

Authors:  Daijiro Morimoto; Daizo Yoshida; Masahiro Noha; Masanori Suzuki; R Yoshiyuki Osamura; Akira Teramoto
Journal:  J Neurooncol       Date:  2006-04-06       Impact factor: 4.130

4.  Enhancement of pituitary adenoma cell invasion and adhesion is mediated by discoidin domain receptor-1.

Authors:  Daizo Yoshida; Akira Teramoto
Journal:  J Neurooncol       Date:  2006-09-26       Impact factor: 4.130

5.  Matrix metalloproteinase-9, a potential biological marker in invasive pituitary adenomas.

Authors:  Jian Gong; Yunge Zhao; Rana Abdel-Fattah; Samson Amos; Aizhen Xiao; M Beatriz S Lopes; Isa M Hussaini; Edward R Laws
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

6.  Fractal dimension as a quantitator of the microvasculature of normal and adenomatous pituitary tissue.

Authors:  Antonio Di Ieva; Fabio Grizzi; Giorgia Ceva-Grimaldi; Carlo Russo; Paolo Gaetani; Enrico Aimar; Daniel Levi; Patrizia Pisano; Flavio Tancioni; Giancarlo Nicola; Manfred Tschabitscher; Nicola Dioguardi; Riccardo Rodriguez Y Baena
Journal:  J Anat       Date:  2007-09-03       Impact factor: 2.610

7.  Magnetic resonance imaging criteria to predict complete excision of parasellar pituitary macroadenoma on postoperative imaging.

Authors:  S E J Connor; F Wilson; K Hogarth
Journal:  J Neurol Surg B Skull Base       Date:  2013-08-21

Review 8.  Aggressive pituitary adenomas--diagnosis and emerging treatments.

Authors:  Antonio Di Ieva; Fabio Rotondo; Luis V Syro; Michael D Cusimano; Kalman Kovacs
Journal:  Nat Rev Endocrinol       Date:  2014-05-13       Impact factor: 43.330

9.  Correlation between histological subtypes and MRI findings in clinically nonfunctioning pituitary adenomas.

Authors:  Hiroshi Nishioka; Naoko Inoshita; Toshiaki Sano; Noriaki Fukuhara; Shozo Yamada
Journal:  Endocr Pathol       Date:  2012-09       Impact factor: 3.943

10.  MGMT expression and pituitary tumours: relationship to tumour biology.

Authors:  Ann McCormack; Warren Kaplan; Anthony J Gill; Nicholas Little; Raymond Cook; Bruce Robinson; Roderick Clifton-Bligh
Journal:  Pituitary       Date:  2013-06       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.